Volkmar Henschel

8.4k citations
44 papers · 5.5k indexed · 4 hit papers · h-index 21
Topics
Advanced Breast Cancer Therapies (12 papers)Cancer Immunotherapy and Biomarkers (11 papers)HER2/EGFR in Cancer Research (6 papers)

In The Last Decade

Volkmar Henschel

44 papers receiving 5.5k citations

Hit Papers

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negati...2015202620182022201820192015202110002.0k3.0k

Peers

Volkmar Henschel
Comparison fields: 5 of 141
  • Oncology 4.0k
  • Pulmonary and Respiratory Medicine 1.9k
  • Immunology 1.3k
  • Cancer Research 1.2k
  • Molecular Biology 967
Replace Hisao Imai with:
Hisao Imai Japan
David Waltregny Belgium
Deendayal Dinakarpandian United States
Jun Akiba Japan
Xiaoyun Liao United States
Masahide Ikeguchi Japan
Peter Bronsert Germany
Bang H. Hoang United States
Kitty B.J.M. Cleutjens Netherlands
Marius Raica Romania
Volkmar Henschel relative to Hisao Imai Japan Hisao Imai's profile →
Citations per field
00.5×3.1×
Hisao Imai · 1×
Citations per year

Countries citing papers authored by Volkmar Henschel

Since Specialization
Citations

This map shows the geographic impact of Volkmar Henschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkmar Henschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkmar Henschel more than expected).

Fields of papers citing papers by Volkmar Henschel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volkmar Henschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkmar Henschel. The network helps show where Volkmar Henschel may publish in the future.

Co-authorship network of co-authors of Volkmar Henschel

This figure shows the co-authorship network connecting the top 25 collaborators of Volkmar Henschel. A scholar is included among the top collaborators of Volkmar Henschel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volkmar Henschel. Volkmar Henschel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 82
2
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysisbreakdown →
293
3 44
4 8
5 60
6
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown →
846
7 9
8
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trialbreakdown →
462
9 42
10 20
11 49
12 27
13 70
14 42
15 24
16 35
17 5
18 88
19 12
20
Exact distributions in the model of a regression line for the threshold parameter with exponential distribution of errors
2

About Volkmar Henschel

Volkmar Henschel is a scholar working on Complementary and Manual Therapy, Oncology and Orthodontics, having authored 44 papers that have together received 5.5k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (1.2k citations) and Immunology (1.3k citations). Volkmar Henschel has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Carlos H. Barrios, Véronique Dièras, Sherene Loi, Leisha A. Emens, Sylvia Adams, Hiroji Iwata, Eric P. Winer, Hope S. Rugo, Luciana Molinero and Jane Yuet Ching Hui. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026